摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6,6'-双(甲基)-2,2'-双(二苯基磷)联苯 | 91548-08-2

中文名称
6,6'-双(甲基)-2,2'-双(二苯基磷)联苯
中文别名
——
英文名称
(RS)-(6,6'-dimethylbiphenyl-2,2'-diyl)bis(diphenylphosphine)
英文别名
(R)-2,2'-bis(diphenylphosphino)-6,6'-dimethyl-1,1'-biphenyl;2,2'-bis(diphenylphosphino)-6,6'-dimethylbiphenyl;2,2'-dimethyl-6,6'-bis(diphenylphosphino)-1,1'-biphenyl;(R)-6,6'-dimethyl-2,2'-bis(diphenylphosphino)-1,1'-biphenyl;(S)-(6,6'-dimethyl-2,2'-biphenylylene)-bis-(diphenylphosphine);(R)-(6,6'-dimethyl-2,2'-biphenylylene)-bis(diphenylphosphine);(6,6'-Dimethylbiphenyl-2,2'-diyl)bis(diphenylphosphine);2,2'-bis(diphenylphosphino)-6,6'-dimethyl-1,1'-biphenyl;MeO-BIPHEP;[2-(2-diphenylphosphanyl-6-methylphenyl)-3-methylphenyl]-diphenylphosphane
6,6'-双(甲基)-2,2'-双(二苯基磷)联苯化学式
CAS
91548-08-2
化学式
C38H32P2
mdl
——
分子量
550.62
InChiKey
WHLQQRGHOPIIMQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    640.9±55.0 °C(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    9.6
  • 重原子数:
    40
  • 可旋转键数:
    7
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.05
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

SDS

SDS:c04d5554e02b5a447d5fd7966524a05a
查看

反应信息

  • 作为反应物:
    描述:
    6,6'-双(甲基)-2,2'-双(二苯基磷)联苯 生成 (R,S)-<6,6'-dimethyl-2'-(diphenylphosphino)biphenyl-2-yl>(diphenylphosphine) oxide
    参考文献:
    名称:
    SCHMID, RUDOLF;CEREGHETTI, MARCO;HELSER, BERND;SCHONHOLZER, PETER;HANSEN,+, HELV. CHIM. ACTA, 71,(1988) N 4, 897-929
    摘要:
    DOI:
  • 作为产物:
    描述:
    (S)-(-)-6,6'-二甲基-2,2'-联苯二胺正丁基锂硫酸 、 potassium iodide 、 sodium nitrite 作用下, 生成 6,6'-双(甲基)-2,2'-双(二苯基磷)联苯
    参考文献:
    名称:
    有效地获得(R)-和(S)-6,6'-二甲氧基-2,2'-二碘-1,1'-联苯
    摘要:
    在一个更好的方法比已知为(外消旋) -图2a,二胺(外消旋) -图2b是解决首次与新的拆分剂([R ,- [R )-和(小号,小号)-2,3-二(苯基氨基-羰基)酒石酸(5c)(40-45%的重量产率;> 99%ee)。将二胺(R)-或(S)-2a和2b以> 98%的立体化学保留率转化为二碘化物(R)-和(S)-3a和3b,随后在不损失光学纯度的情况下,将二苯膦化成已知的二膦(R)-和(S)-4a和4b。
    DOI:
    10.1016/0040-4039(96)01089-1
  • 作为试剂:
    描述:
    n-(2-羟基苯基)-甲烷磺酰胺carbonic acid (Z)-4-methoxycarbonyloxy-but-2-enyl ester methyl ester6,6'-双(甲基)-2,2'-双(二苯基磷)联苯1,4-双(二苯基膦)丁烷 作用下, 以 四氢呋喃 为溶剂, 反应 24.0h, 生成 (R)-2-vinyl-3,4-dihydro-2H-1,4-benzoxazine 、 (S)-2-vinyl-3,4-dihydro-2H-1,4-benzoxazine
    参考文献:
    名称:
    Lhoste, Paul; Massacret, Magali; Sinou, Denis, Bulletin de la Societe Chimique de France, 1997, vol. 134, # 3-4, p. 343 - 348
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • HYDROGENATION OF ESTERS OR CARBONYL GROUPS WITH PHOSPHINO-OXIDE BASED RUTHENIUM COMPLEXES
    申请人:Saudan Lionel
    公开号:US20110190523A1
    公开(公告)日:2011-08-04
    The present invention relates to the field of catalytic hydrogenation and, more particularly, to the use of specific ruthenium catalysts or pre-catalysts in hydrogenation processes for the reduction of ketones, aldehydes, esters or lactones into their corresponding alcohols or diols respectively. The preferred catalysts are ruthenium complexes comprising a ligand of the type (N—N) type and a ligand of the type (P—PO).
    本发明涉及催化加氢领域,更具体地涉及在加氢过程中使用特定的催化剂或前驱体,用于将酮、醛、酯或内酯还原为相应的醇或二醇。首选催化剂是包含(N—N)型配体和(P—PO)型配体配合物。
  • Axially Asymmetric Phosphorus Compound and Production Method Thereof
    申请人:Tanaka Ken
    公开号:US20090227805A1
    公开(公告)日:2009-09-10
    Problem to be Solved: To provide an axially asymmetric optically active biarylphosphorus compound that can easily produced without the step of optical resolution which was almost indispensable in conventional methods. Solution: A method for producing an axially asymmetric phosphorus compound represented by the general formula (1), comprising a cycloaddition reaction of a compound having a triple bond with the use of a catalyst containing rhodium metal and an optically active bisphosphine. (In the formula, J is an oxygen atom, a sulfur atom or BH 3 ; R 1 and R 2 independently are an alkyl, cycloalkyl, aryl, alkoxy and aryloxy group; a1 and a2 independently are 0 or 1; R 3 to R 10 independently are an alkyl, cycloalkyl, aryl, alkoxy and aryloxy group; two among R 3 to R 10 may form a ring; and * is axial asymmetry.)
    要解决的问题:提供一种轴向不对称的光学活性联苯化合物,可以在传统方法中几乎不可或缺的光学分辨步骤之外轻松生产。 解决方案:一种生产由通式(1)表示的轴向不对称化合物的方法,包括使用含有属和光学活性双膦的催化剂进行含有三键化合物的环加成反应。 (在公式中,J是氧原子、原子或BH3;R1和R2独立地是烷基、环烷基、芳基、烷氧基和芳氧基;a1和a2独立地为0或1;R3到R10独立地是烷基、环烷基、芳基、烷氧基和芳氧基;R3到R10中的两个可能形成环;*表示轴向不对称。)
  • METHOD FOR PRODUCING ALCOHOL COMPOUND
    申请人:Shimizu Hideo
    公开号:US20110201819A1
    公开(公告)日:2011-08-18
    Disclosed is a practical method for efficiently producing an alcohol compound by hydrogenating an aldehyde by using a homogeneous copper catalyst which is an easily-available low-cost metal species. Specifically disclosed is a method for producing an alcohol compound, which is characterized in that a hydrogenation reaction of an aldehyde compound is performed in the presence of a homogeneous copper catalyst and a diphosphine compound.
    本文揭示了一种实用的方法,通过使用易获得的低成本属种类——均相催化剂,通过氢化醛类化合物高效产生醇类化合物。具体揭示了一种产生醇类化合物的方法,其特点在于在均相催化剂和二膦化合物存在下进行醛类化合物的氢化反应。
  • [EN] PROCESS FOR THE PREPARATION OF SPHINGOSINE-1-PHOSPHATE RECEPTOR AGONIST<br/>[FR] PROCÉDÉ DE PRÉPARATION D'UN AGONISTE DU RÉCEPTEUR DE LA SPHINGOSINE-1-PHOSPHATE
    申请人:QUIM SINTETICA S A
    公开号:WO2020064818A1
    公开(公告)日:2020-04-02
    Industrially viable and advantageous processes for the preparation of Ozanimod are described. The invention also discloses the intermediates obtained in the process.
    描述了用于制备奥扎尼莫德的工业可行且有利的工艺。该发明还披露了在该过程中获得的中间体。
  • PROCESS FOR PRODUCING PHENYL-SUBSTITUTED HETEROCYCLIC DERIVATIVE THROUGH COUPLING USING TRANSITION METAL CATALYST
    申请人:Komiyama Masato
    公开号:US20110313169A1
    公开(公告)日:2011-12-22
    A process for efficiently producing, through few steps either a xanthine oxidase inhibitor, which is a therapeutic agent for hyperuricemia, or an intermediate therefore. The process is a novel coupling process which comprises subjecting a compound represented by formula (1) to coupling reaction with a compound represented by formula (2) in the presence of a transition metal compound to thereby obtain a compound represented by formula (3).
    一种高效生产黄嘌呤氧化酶抑制剂或其中间体的方法,该抑制剂是治疗高尿酸血症的药物。该方法是一种新型偶联过程,包括将式(1)表示的化合物与式(2)表示的化合物在过渡属化合物存在下进行偶联反应,从而获得式(3)表示的化合物。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫